These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 16048597

  • 21. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.
    Transplantation; 1998 Aug 15; 66(3):318-23. PubMed ID: 9721799
    [Abstract] [Full Text] [Related]

  • 22. Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation.
    Miura M, Harada H, Fukuzawa N, Iwami D, Taniguchi A, Seki T, Togashi M, Ogawa Y, Satoh H, Hirano T.
    Clin Transplant; 2005 Aug 15; 19 Suppl 14():54-8. PubMed ID: 15955170
    [Abstract] [Full Text] [Related]

  • 23. Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.
    Teraoka S, Sato S, Sekijima M, Iwado K, Urashima Y, Kudo S, Kai K, Koyama I, Tojinbara T, Nakajima I, Fuchinoue S.
    Transplant Proc; 2005 Mar 15; 37(2):791-4. PubMed ID: 15848533
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
    Phanish MK, Hull RP, Andrews PA, Popoola J, Kingdon EJ, MacPhee IAM, South West Thames Renal Transplantation Network.
    BMC Nephrol; 2020 Mar 11; 21(1):92. PubMed ID: 32160893
    [Abstract] [Full Text] [Related]

  • 28. Basiliximab induction in renal transplantation: long-term outcome.
    Atlani M, Sharma RK, Gupta A.
    Saudi J Kidney Dis Transpl; 2013 May 11; 24(3):473-9. PubMed ID: 23640617
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.
    Kuypers DR, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.
    Clin Transplant; 2003 Jun 11; 17(3):234-41. PubMed ID: 12780674
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
    Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS.
    Transplantation; 1998 Jan 27; 65(2):180-7. PubMed ID: 9458011
    [Abstract] [Full Text] [Related]

  • 35. Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
    Refaie AF, Mahmoud KM, Ismail AM, Sheashaa HA, Kamal AI, Ghoneim MA.
    Exp Clin Transplant; 2011 Oct 27; 9(5):295-301. PubMed ID: 21967254
    [Abstract] [Full Text] [Related]

  • 36. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.
    Höcker B, Weber LT, Feneberg R, Drube J, John U, Fehrenbach H, Pohl M, Zimmering M, Fründ S, Klaus G, Wühl E, Tönshoff B.
    Transplantation; 2009 Mar 27; 87(6):934-41. PubMed ID: 19300199
    [Abstract] [Full Text] [Related]

  • 37. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation.
    Lo A, Stratta RJ, Alloway RR, Egidi MF, Shokouh-Amiri MH, Grewal HP, Gaber LW, Gaber AO.
    Transpl Int; 2001 Dec 27; 14(6):396-404. PubMed ID: 11793037
    [Abstract] [Full Text] [Related]

  • 38. Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols.
    Chkhotua AB, Klein T, Shabtai E, Yussim A, Bar-Nathan N, Shaharabani E, Lustig S, Mor E.
    Urology; 2003 Dec 27; 62(6):1002-6. PubMed ID: 14665344
    [Abstract] [Full Text] [Related]

  • 39. Rejection is a strong graft survival predictor in live donor pediatric renal transplantation using cyclosporine, mycophenolate mofetil, and steroids: 5-year outcomes in a single Mexican center.
    Martinez-Mier G, Enriquez-De Los Santos H, Méndez-López MT, Avila-Pardo SF, Budar-Fernandez LF, Gonzalez-Velazquez F.
    Transplant Proc; 2013 May 27; 45(4):1442-4. PubMed ID: 23726592
    [Abstract] [Full Text] [Related]

  • 40. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
    Birkeland SA.
    Transplantation; 2001 Apr 27; 71(8):1089-90. PubMed ID: 11374407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.